IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$0.12
+0.00 (+0.89%)
As of Aug 8, 2:29 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,743.4% upside
Low Target $2.21
Average Target $3.54
High Target $4.26
Current Price $0.12
Current
$0.12
Target
$3.54
$2.21 $3.54 avg $4.26
Scenario Analysis
Bear Case
$2.21
1,675.1%
Low target
Base Case
$3.54
+2,743.4%
Avg target
Bull Case
$4.26
+3,321.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.16
-96.1% from high
52-Week Low
$0.48
+-73.8% from low
Target vs 52W High
$3.54
+12.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%